APA Citatie

Kim, S., Park, A. K., Chaurasiya, S., Kang, S., Lu, J., Yang, A., . . . Warner, S. G. (2020). Recombinant orthopoxvirus primes colon cancer for checkpoint inhibitor and cross-primes T cells for anti-tumor and anti-viral immunity. Mol Cancer Ther.

Chicago Style citaat

Kim, Sang-In, et al. "Recombinant Orthopoxvirus Primes Colon Cancer for Checkpoint Inhibitor and Cross-primes T Cells for Anti-tumor and Anti-viral Immunity." Mol Cancer Ther 2020.

MLA citatie

Kim, Sang-In, et al. "Recombinant Orthopoxvirus Primes Colon Cancer for Checkpoint Inhibitor and Cross-primes T Cells for Anti-tumor and Anti-viral Immunity." Mol Cancer Ther 2020.